DAYVIGO
NDC 62856-410, lemborexant, tablet, film coated, from Eisai Inc..
- Product NDC
- 62856-410
- Status
- Listed
- Labeler
- Eisai Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212028
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/62856-410 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEMBOREXANT10 mg/1
Pharmacologic classes
Cytochrome P450 2B6 Inducers [MoA]; Orexin Receptor Antagonist [EPC]; Orexin Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62856-410-30 | 62856041030 | 30 TABLET, FILM COATED in 1 BOTTLE (62856-410-30) |
| 62856-410-90 | 62856041090 | 90 TABLET, FILM COATED in 1 BOTTLE (62856-410-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7074cb65-77b3-45d2-8e8d-da8dc0f70bfdNADAC price for package 62856041030
GET /v1/drugs/nadac/62856041030
Use it
Look up 62856-410 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62856-410 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62856-410. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.